Last updated on November 2017

Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)


Brief description of study

Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)

Detailed Study Description

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1-3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder

Clinical Study Identifier: TX10053

Contact Investigators or Research Sites near you

Start Over

Segal Institute for Clinical Research

Segal Institute for Clinical Research
North Miami, FL USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.